Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
2000 2
2001 11
2002 74
2003 53
2004 61
2005 63
2006 56
2007 71
2008 86
2009 94
2010 90
2011 86
2012 80
2013 76
2014 69
2015 55
2016 37
2017 36
2018 28
2019 16
2020 19
2021 12
2022 10
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

PubMed (GeneRIF) for id: 355

1,038 results

Results by year

Filters applied: . Clear all
Page 1
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells.
Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, Bakardjieva M, Stancikova J, Raabe J, Neumann J, Schwenk S, Arpesella L, Stuchly J, Benes V, García Valiente R, Fernández García J, Carsetti R, Piano Mortari E, Catala A, de la Calle O, Sogkas G, Neven B, Rieux-Laucat F, Magerus A, Neth O, Olbrich P, Voll RE, Alsina L, Allende LM, Gonzalez-Granado LI, Böhler C, Thiel J, Venhoff N, Lorenzetti R, Warnatz K, Unger S, Seidl M, Mielenz D, Schneider P, Ehl S, Rensing-Ehl A, Smulski CR, Rizzi M. Staniek J, et al. Sci Immunol. 2024 Jan 12;9(91):eadj5948. doi: 10.1126/sciimmunol.adj5948. Epub 2024 Jan 12. Sci Immunol. 2024. PMID: 38215192
Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
Rensing-Ehl A, Lorenz MR, Führer M, Willenbacher W, Willenbacher E, Sopper S, Abinun M, Maccari ME, König C, Haegele P, Fuchs S, Castro C, Kury P, Pelle O, Klemann C, Heeg M, Thalhammer J, Wegehaupt O, Fischer M, Goldacker S, Schulte B, Biskup S, Chatelain P, Schuster V, Warnatz K, Grimbacher B, Meinhardt A, Holzinger D, Oommen PT, Hinze T, Hebart H, Seeger K, Lehmberg K, Leahy TR, Claviez A, Vieth S, Schilling FH, Fuchs I, Groß M, Rieux-Laucat F, Magerus A, Speckmann C, Schwarz K, Ehl S; ALPS Study Group. Rensing-Ehl A, et al. J Allergy Clin Immunol. 2024 Jan;153(1):297-308.e12. doi: 10.1016/j.jaci.2023.11.006. Epub 2023 Nov 17. J Allergy Clin Immunol. 2024. PMID: 37979702
Blood soluble Fas concentrations and ischemic stroke patient mortality.
Lorente L, Martín MM, Pérez-Cejas A, Ferrer-Moure C, Ramos-Gómez L, Solé-Violán J, Cáceres JJ, Jiménez A, González-Rivero AF. Lorente L, et al. Expert Rev Mol Diagn. 2022 Dec;22(12):1117-1121. doi: 10.1080/14737159.2022.2165913. Epub 2023 Jan 9. Expert Rev Mol Diagn. 2022. PMID: 36621530
Clinical and immunological analysis of a large kindred affected by autoimmune lymphoproliferative syndrome (ALPS) due to a novel TNFRSF6 mutation displaying age dependent disease activity.
Tessarin G, Baronio M, Gazzurelli L, Rossi S, Gorio C, Bertoni E, Chiarini M, Moratto D, Mazza C, Porta F, Badolato R, Lougaris V. Tessarin G, et al. Clin Immunol. 2022 Dec;245:109136. doi: 10.1016/j.clim.2022.109136. Epub 2022 Sep 30. Clin Immunol. 2022. PMID: 36184054 No abstract available.
1,038 results